
Mesa Laboratories, Inc.
MLABNASDAQHealthcareMedical - Specialties
Previous close
$124.76
+$5.61 · +4.71%
MLAB company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
58
Fair Value
Momentum
48
Neutral
Sentiment
58
Mixed
Risk resilience
52
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteMesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
- Industry
- Medical - Specialties
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Siddhartha C. Kadia
- Listed since
- Feb 29, 1984
- Employees
- 717
Market position
Day range
Current $124.76
52-week range
Current $124.76
- Open
- $117.27
- Previous close
- $119.15
- Volume
- 160.69K
- 0.89× average
- Average volume
- 180.62K
- Average daily volume
- Market cap
- 698.14M USD
- Beta
- 0.93
- Market reference 1
- 50-day average
- $101.72
- +22.65% above average
- 200-day average
- $91.9875
- +35.63% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 629.45M USD
- P/E (TTM)
- 145.07×
- P/B (TTM)
- 3.74×
- P/S (TTM)
- 2.8×
- EV / EBITDA
- 17.84×
- Earnings yield
- 1.38%
- Free cash flow yield
- 8.12%
- Dividend yield
- 0.51%
Profitability & efficiency
- Gross margin
- 65.99%
- Operating margin
- 9.00%
- Net margin
- 1.92%
- Return on equity
- 3.60%
- Return on assets
- 1.57%
- Return on invested capital
- 2.76%
Financial health
- Debt / equity
- 0.54×
- Current ratio
- 1.72×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 249.13M USD | 240.98M USD | 216.19M USD | 219.08M USD | 184.34M USD |
| Cost of goods sold | 90.86M USD | 90.11M USD | 82.94M USD | 85.39M USD | 75.25M USD |
| Gross profit | 158.27M USD | 150.87M USD | 133.25M USD | 133.69M USD | 109.09M USD |
| Research and development | 20.31M USD | 19.52M USD | 19.3M USD | 20.49M USD | 15.77M USD |
| Selling, general, and administrative | 119.45M USD | 115.02M USD | 111.49M USD | 109.88M USD | 88.62M USD |
| Operating expenses | 139.76M USD | 134.53M USD | 405.33M USD | 130.37M USD | 104.39M USD |
| Interest expense | 10.69M USD | 11.86M USD | 5.7M USD | 4.77M USD | 3.89M USD |
| Depreciation and amortization | 23.27M USD | 24.53M USD | 31.57M USD | 33.13M USD | 25.07M USD |
| Operating income | 18.51M USD | 16.34M USD | −272.08M USD | 3.32M USD | 4.7M USD |
| Net income | 6.71M USD | −1.97M USD | −254.25M USD | 930K USD | 1.87M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 55%
- 6 beats, 5 misses, 0 met estimates
- Average EPS surprise
- +257.45%
- 11 comparable reports
- Latest EPS result
- 2.68
- Estimate 2.63 · Beat by 1.90%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Rating distribution
8 ratingsMLAB peers
ETFs holding MLAB
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI16.99M0.00%2.3T USD0.03%$378.24+0.44%
iShares Russell 2000 ETFIWM16.29M0.02%81.62B USD0.19%$299.96+0.77%
Keeley Dividend ETFKDVD14.87M2.06%7.2M USD0.90%$29.00010.00%
Fidelity Enhanced Small Cap ETFFESM10.03M0.15%6.03B USD0.28%$47.94+0.80%
Vanguard Extended Market ETFVXF6.4M0.01%93.7B USD0.05%$245.53+0.82%
iShares Russell 2000 Growth ETFIWO5.99M0.04%15.16B USD0.24%$387.37+1.24%
Schwab U.S. Small-Cap ETFSCHA3.3M0.01%23.1B USD0.03%$34.83+0.52%
Dimensional - US Targeted Value ETFDFAT3.28M0.02%14.66B USD0.28%$71.67+0.67%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 16.99M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
iShares Russell 2000 ETFIWM- Market value
- 16.29M
- Weight
- 0.02%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
Keeley Dividend ETFKDVD- Market value
- 14.87M
- Weight
- 2.06%
- AUM
- 7.2M USD
- Expense ratio
- 0.90%
- Price / 1D
- $29.00010.00%
Fidelity Enhanced Small Cap ETFFESM- Market value
- 10.03M
- Weight
- 0.15%
- AUM
- 6.03B USD
- Expense ratio
- 0.28%
- Price / 1D
- $47.94+0.80%
Vanguard Extended Market ETFVXF- Market value
- 6.4M
- Weight
- 0.01%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
iShares Russell 2000 Growth ETFIWO- Market value
- 5.99M
- Weight
- 0.04%
- AUM
- 15.16B USD
- Expense ratio
- 0.24%
- Price / 1D
- $387.37+1.24%
Schwab U.S. Small-Cap ETFSCHA- Market value
- 3.3M
- Weight
- 0.01%
- AUM
- 23.1B USD
- Expense ratio
- 0.03%
- Price / 1D
- $34.83+0.52%
Dimensional - US Targeted Value ETFDFAT- Market value
- 3.28M
- Weight
- 0.02%
- AUM
- 14.66B USD
- Expense ratio
- 0.28%
- Price / 1D
- $71.67+0.67%
Continue in GoAI
Research MLABresearch.disclaimer





